Produktbild
Mike S. (Hrsg.) Lee

Mass Spectrometry in Drug Metabolism and Disposition

Basic Principles and Applications

Ebook (PDF Format)

The pioneering guide to solving real-world problems in drug metabolism using mass spectrometry Mass spectrometry has become the predominant analytical tool for drug metabolism and pharmacokinetics research in modern drug discovery and development. This book represents a coherent integration of all relevant background knowledge and detail surrounding the analytical technologies in this new multidisciplinary field. With chapters written by internationally renowned authors, the book provides details on: Basic concepts of drug metabolism and pharmacokinetics The principles and common practice of mass spectrometry in drug metabolism Applications… Mehr

CHF 118.00

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen
Versandkostenfrei

Produktdetails


Weitere Autoren: Zhu, Mingshe (Hrsg.)
  • ISBN: 978-0-470-92926-1
  • EAN: 9780470929261
  • Produktnummer: 13793140
  • Verlag: Wiley
  • Sprache: Englisch
  • Erscheinungsjahr: 2010
  • Seitenangabe: 608 S.
  • Plattform: PDF
  • Masse: 16'423 KB

Über den Autor


MIKE S. LEE, PhD, is President of Milestone Development Services. His recent work has involved the development of automated orthogonal control systems for electrospray ionization. Formerly, Dr. Lee was director of analytical research and development at Bristol-Myers Squibb (BMS) Pharmaceutical Research Institute where he led interdisciplinary teams that contributed to the Food and Drug Administration's approval of Buspar® and Serzone®, and the accelerated development and approval of Taxol®. In addition, he has authored over forty scientific papers and issued patents. MINGSHE ZHU, PhD, is a drug metabolism researcher at Bristol-Myers Squibb, where he leads a team that investigates biotransformation in new drug discovery and preclinical drug metabolism and pharmacokinetics in development. His teams have provided key metabolism and disposition information for regulatory approval of Abilify® and NDA submission of Dapagliflozin. Dr. Zhu's research interests include LC/MS technology, optimization of ADME properties, metabolic activation, and regulatory drug metabolism. He has been frequently invited to speak and teach short courses at conferences/workshops and has coauthored over sixty research articles and one book.

10 weitere Werke von Mike S. (Hrsg.) Lee:


Bewertungen


0 von 0 Bewertungen

Geben Sie eine Bewertung ab!

Teilen Sie Ihre Erfahrungen mit dem Produkt mit anderen Kunden.